Close

Nomura Securities Starts Tetralogic Pharmaceuticals (TLOG) at Buy

June 26, 2014 7:56 AM EDT Send to a Friend
Nomura Securities initiates coverage on Tetralogic Pharmaceuticals (NASDAQ: TLOG) with a Buy rating and a price target of $9.00.Analyst Do ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login